Enhancement of Biomarkers for Type 1 Diabetes (H-41091)
Description
Content
Study Goal(s): To utilize immunologic biomarkers, in particular a variant-specific IA-2 autoantibodies, for type 1 diabetes prediction
Eligibility Criteria: Individuals with type 1 diabetes
Investigators: Massimo Pietropaolo, M.D. (principal investigator), Maria J. Redondo M.D., Ph.D. (co-investigator)
Supported by: National institutes of Health, R01 Award
Contact
IRB: H-41091
Status:
Active
Created:
